JCI Table of Contents, December 2, 2002

**Please mention the Journal of Clinical Investigation as the source of these articles**

Find below two highlighted articles and the full Table of Contents for the December 2, 2002 issue


Restoration of Faulty Blood Vessel Architecture by Angiopoietin-1

Angiogenesis (the growth of new blood vessels) requires complex signaling between multiple cell types, and abnormalities in these pathways results in faulty vessels. During normal vessel formation endothelial cells that comprise the blood vessel communicate, through a number of secreted agents called growth factors, with a family of cells known as mural cells. Endothelial cells secrete the growth factor PDGF B that is bound to mural cells by the PDGF-b receptor. Murals cells are then recruited to the new vessel where upon direct interaction with endothelial cells they secrete angiopoietin-1 (Ang1). Multiple roles in vessel maturation have been designated to Ang1 and they include sprouting, survival and stability of the new vessel. However, the exact nature of its involvement is unclear. The critical interactions between endothelial cells and mural cells facilitate the growth and maturation of new blood vessels. In diseases such as diabetic retinopathy, mural cells are absent from the vessel maturation process, which results in abnormal vessels growing on top of the retina, which can lead to blindness. The complex mechanisms by which mural cells regulate the activity of endothelial cells is also unclear. One way to investigate this relationship would be to develop an experimental system in which mural cells and endothelial cells are separated, yet new blood vessels still develop. As this development usually happens in the early embryo, it has been a difficult experimental system to manipulate. In the December 2 issue of the Journal of Clinical Investigation, Akiyoshi Uemura a

Contact: Brooke Grindlinger, PhD
Journal of Clinical Investigation

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology news :

1. JCI Table of Contents, 15 July 2004
2. JCI Table of Contents, January 15 2004
3. JCI Table of Contents, November 3, 2003
4. JCI Table of Contents, 1 October, 2003
5. JCI Table of Contents, September 15, 2003
6. JCI Table of Contents
7. JCI Table of Contents, 15 August 2003
8. JCI Table of Contents, May 1, 2003
9. JCI Table of Contents, April 1, 2003
10. JCI Table of Contents, March 14, 2003
11. JCI Table of Contents, January 2, 2003

Post Your Comments:

(Date:8/26/2020)... ... ... Modality Solutions, a biopharmaceutical cold chain validation engineering firm, is ... is the most prestigious ranking of the nation’s fastest-growing private companies. Modality Solutions made ... three-year revenue growth of 71 percent. , The Inc. 5000 list represents a ...
(Date:8/21/2020)... ... August 19, 2020 , ... The 19th Annual Bio-IT ... data science, informatics and IT leaders goes VIRTUAL and announces its updated event ... change, Bio-IT takes the leadership role of keeping our life science community connected ...
(Date:8/7/2020)... ... August 06, 2020 , ... Alucio™, a fast-growing provider ... Eric Chen and Jessica Wong have joined the company’s leadership team as Vice ... Eric Chen heads development efforts for Alucio’s flagship product, Beacon, an innovative cloud-based ...
Breaking Biology News(10 mins):
(Date:8/31/2020)... (PRWEB) , ... August 29, 2020 , ... ... new Animal Nutrition manufacturing capability in Wuxi, China. The new plant operation will ... quality standards and advanced technology. , “This facility will improve the flexibility ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), ... The network is a consortium of academic research centers in the United States ...
(Date:8/7/2020)... (PRWEB) , ... August 06, 2020 , ... ... DNA vaccine industries, announces it has closed on the purchase of greenfield for ... in Conroe, TX and includes over 21 acres in the initial acquisition, with ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International ... only $3950. With 50 million stem cells total, patients may choose which extremities they ... works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue ...
Breaking Biology Technology:
Cached News: